# Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

> **NCT06638541** · NA · RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 54 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Prostate radical radiotherapy

## Key facts

- **NCT ID:** NCT06638541
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638541, "Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06638541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*